vTv Therapeutics Inc. (VTVT)
NASDAQ: VTVT · Real-Time Price · USD
15.46
-0.97 (-5.90%)
Nov 20, 2024, 4:00 PM EST - Market closed
vTv Therapeutics Market Cap
vTv Therapeutics has a market cap or net worth of $46.54 million as of November 21, 2024. Its market cap has increased by 16.64% in one year.
Market Cap
46.54M
Enterprise Value
-926.03K
1-Year Change
16.64%
Ranking
Category
Stock Price
$15.46
Market Cap Chart
Since July 30, 2015, vTv Therapeutics's market cap has decreased from $357.30M to $46.54M, a decrease of -86.98%. That is a compound annual growth rate of -19.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 52.40M | 74.09% |
| Dec 29, 2023 | 30.10M | -56.57% |
| Dec 30, 2022 | 69.30M | -22.66% |
| Dec 31, 2021 | 89.60M | -34.79% |
| Dec 31, 2020 | 137.40M | 34.97% |
| Dec 31, 2019 | 101.80M | -5.74% |
| Dec 31, 2018 | 108.00M | -45.23% |
| Dec 29, 2017 | 197.20M | 24.42% |
| Dec 30, 2016 | 158.50M | -29.08% |
| Dec 31, 2015 | 223.50M | -37.45% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aadi Bioscience | 52.50M |
| Prelude Therapeutics | 52.04M |
| Kronos Bio | 51.25M |
| Cytosorbents | 50.97M |
| Rapid Micro Biosystems | 50.87M |
| Vor Biopharma | 50.75M |
| LakeShore Biopharma | 50.09M |
| Lucid Diagnostics | 49.71M |